The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-09-06

AUTHORS

Christopher P. Karch, Tais A. P. F. Doll, Sara M. Paulillo, Issa Nebie, David E. Lanar, Giampietro Corradin, Peter Burkhard

ABSTRACT

BackgroundThe parasitic disease malaria remains a major global public health concern and no truly effective vaccine exists. One approach to the development of a malaria vaccine is to target the asexual blood stage that results in clinical symptoms. Most attempts have failed. New antigens such as P27A and P27 have emerged as potential new vaccine candidates. Multiple studies have demonstrated that antigens are more immunogenic and are better correlated with protection when presented on particulate delivery systems. One such particulate delivery system is the self-assembling protein nanoparticle (SAPN) that relies on coiled-coil domains of proteins to form stable nanoparticles. In the past we have used de novo designed amino acid domains to drive the formation of the coiled-coil scaffolds which present the antigenic epitopes on the particle surface.ResultsHere we use naturally occurring domains found in the tex1 protein to form the coiled-coil scaffolding of the nanoparticle. Thus, by engineering P27A and a new extended form of the coiled-coil domain P27 onto the N and C terminus of the SAPN protein monomer we have developed a particulate delivery system that effectively displays both antigens on a single particle that uses malaria tex1 sequences to form the nanoparticle scaffold. These particles are immunogenic in a murine model and induce immune responses similar to the ones observed in seropositive individuals in malaria endemic regions.ConclusionsWe demonstrate that our P27/P27A-SAPNs induce an immune response akin to the one in seropositive individuals in Burkina Faso. Since P27 is highly conserved among different Plasmodium species, these novel SAPNs may even provide cross-protection between Plasmodium falciparum and Plasmodium vivax the two major human malaria pathogens. As the SAPNs are also easy to manufacture and store they can be delivered to the population in need without complication thus providing a low cost malaria vaccine. More... »

PAGES

62

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12951-017-0295-0

DOI

http://dx.doi.org/10.1186/s12951-017-0295-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1091498894

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28877692


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Protozoan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Malaria Vaccines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Malaria, Falciparum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred BALB C", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Molecular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasmodium falciparum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proliferating Cell Nuclear Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Domains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protozoan Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.63054.34", 
          "name": [
            "Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karch", 
        "givenName": "Christopher P.", 
        "id": "sg:person.011611270371.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011611270371.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.63054.34", 
          "name": [
            "Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doll", 
        "givenName": "Tais A. P. F.", 
        "id": "sg:person.01242722614.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242722614.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Alpha-O Peptides AG, 4125, Riehen, Switzerland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Alpha-O Peptides AG, 4125, Riehen, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Paulillo", 
        "givenName": "Sara M.", 
        "id": "sg:person.01001410103.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001410103.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre National de Recherche et de Formation sur le Paludisme, 01 BP 2208, Ouagadougou, West Africa, Burkina Faso", 
          "id": "http://www.grid.ac/institutes/grid.507461.1", 
          "name": [
            "Centre National de Recherche et de Formation sur le Paludisme, 01 BP 2208, Ouagadougou, West Africa, Burkina Faso"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nebie", 
        "givenName": "Issa", 
        "id": "sg:person.0635025104.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635025104.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Malaria Vaccine Branch, USMMRP-WRAIR, Walter Reed Army Institute of Research, 20910, Silver Spring, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.507680.c", 
          "name": [
            "Malaria Vaccine Branch, USMMRP-WRAIR, Walter Reed Army Institute of Research, 20910, Silver Spring, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lanar", 
        "givenName": "David E.", 
        "id": "sg:person.0727611600.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727611600.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Biochemistry Department, University of Lausanne, 1066, Epalinges, Switzerland", 
          "id": "http://www.grid.ac/institutes/grid.9851.5", 
          "name": [
            "Biochemistry Department, University of Lausanne, 1066, Epalinges, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Corradin", 
        "givenName": "Giampietro", 
        "id": "sg:person.0603746767.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603746767.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Molecular and Cell Biology, University of Connecticut, 06269-3125, Storrs, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.63054.34", 
          "name": [
            "Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA", 
            "Alpha-O Peptides AG, 4125, Riehen, Switzerland", 
            "Department of Molecular and Cell Biology, University of Connecticut, 06269-3125, Storrs, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burkhard", 
        "givenName": "Peter", 
        "id": "sg:person.01203205441.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203205441.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1475-2875-11-361", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008723107", 
          "https://doi.org/10.1186/1475-2875-11-361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2105-11-568", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001814252", 
          "https://doi.org/10.1186/1471-2105-11-568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/336778a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051520883", 
          "https://doi.org/10.1038/336778a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1475-2875-12-136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027971905", 
          "https://doi.org/10.1186/1475-2875-12-136"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-09-06", 
    "datePublishedReg": "2017-09-06", 
    "description": "BackgroundThe parasitic disease malaria remains a major global public health concern and no truly effective vaccine exists. One approach to the development of a malaria vaccine is to target the asexual blood stage that results in clinical symptoms. Most attempts have failed. New antigens such as P27A and P27 have emerged as potential new vaccine candidates. Multiple studies have demonstrated that antigens are more immunogenic and are better correlated with protection when presented on particulate delivery systems. One such particulate delivery system is the self-assembling protein nanoparticle (SAPN) that relies on coiled-coil domains of proteins to form stable nanoparticles. In the past we have used de novo designed amino acid domains to drive the formation of the coiled-coil scaffolds which present the antigenic epitopes on the particle surface.ResultsHere we use naturally occurring domains found in the tex1 protein to form the coiled-coil scaffolding of the nanoparticle. Thus, by engineering P27A and a new extended form of the coiled-coil domain P27 onto the N and C terminus of the SAPN protein monomer we have developed a particulate delivery system that effectively displays both antigens on a single particle that uses malaria tex1 sequences to form the nanoparticle scaffold. These particles are immunogenic in a murine model and induce immune responses similar to the ones observed in seropositive individuals in malaria endemic regions.ConclusionsWe demonstrate that our P27/P27A-SAPNs induce an immune response akin to the one in seropositive individuals in Burkina Faso. Since P27 is highly conserved among different Plasmodium species, these novel SAPNs may even provide cross-protection between Plasmodium falciparum and Plasmodium vivax the two major human malaria pathogens. As the SAPNs are also easy to manufacture and store they can be delivered to the population in need without complication thus providing a low cost malaria vaccine.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12951-017-0295-0", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2457498", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1031280", 
        "issn": [
          "1477-3155"
        ], 
        "name": "Journal of Nanobiotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "15"
      }
    ], 
    "keywords": [
      "self-assembling protein nanoparticles", 
      "particulate delivery systems", 
      "delivery system", 
      "nanoparticle scaffolds", 
      "protein nanoparticles", 
      "stable nanoparticles", 
      "protein nanoparticle vaccine", 
      "nanoparticles", 
      "nanoparticle vaccine", 
      "seropositive individuals", 
      "malaria vaccine", 
      "immune response", 
      "particle surface", 
      "major global public health concern", 
      "new extended form", 
      "potential new vaccine candidates", 
      "parasitic disease malaria", 
      "effective vaccine exists", 
      "global public health concern", 
      "malaria-endemic regions", 
      "human malaria pathogen", 
      "new vaccine candidates", 
      "different Plasmodium species", 
      "public health concern", 
      "asexual blood stages", 
      "vaccine exists", 
      "clinical symptoms", 
      "murine model", 
      "vaccine candidates", 
      "Plasmodium vivax", 
      "new antigens", 
      "endemic regions", 
      "scaffolds", 
      "blood stages", 
      "health concern", 
      "Plasmodium falciparum", 
      "single particle", 
      "vaccine", 
      "antigenic epitopes", 
      "Plasmodium species", 
      "disease malaria", 
      "antigen", 
      "multiple studies", 
      "p27", 
      "particles", 
      "malaria", 
      "malaria pathogen", 
      "de novo", 
      "P27A", 
      "complications", 
      "Burkina Faso", 
      "symptoms", 
      "vivax", 
      "individuals", 
      "surface", 
      "falciparum", 
      "response", 
      "candidates", 
      "amino acid domain", 
      "system", 
      "epitopes", 
      "acid domain", 
      "protein", 
      "ConclusionsWe", 
      "protein monomers", 
      "coiled-coil domain", 
      "pathogens", 
      "population", 
      "ResultsHere", 
      "C-terminus", 
      "novo", 
      "study", 
      "Faso", 
      "formation", 
      "domain", 
      "most attempts", 
      "protection", 
      "monomers", 
      "need", 
      "use", 
      "stage", 
      "concern", 
      "approach", 
      "development", 
      "scaffolding", 
      "sequence", 
      "exists", 
      "attempt", 
      "terminus", 
      "region", 
      "one", 
      "form", 
      "model", 
      "extended form", 
      "species", 
      "past"
    ], 
    "name": "The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria", 
    "pagination": "62", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1091498894"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12951-017-0295-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28877692"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12951-017-0295-0", 
      "https://app.dimensions.ai/details/publication/pub.1091498894"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_746.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12951-017-0295-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12951-017-0295-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12951-017-0295-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12951-017-0295-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12951-017-0295-0'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      21 PREDICATES      140 URIs      129 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12951-017-0295-0 schema:about N0e5162830aa24f10a3af0b4b96759042
2 N1f259d51bf8549ed8d3675e9551bd147
3 N206e5c56b0824683836c1de6be806b7c
4 N3545a3b641d54370a7eca86820a72fb2
5 N3ad620e933264dbc9d3d0dd0667c014d
6 N46941af2721d4e93b688a4f6a9a14854
7 N4770ca4cf8424f2396cb6b0c6ae6c850
8 N5072683e0d0f456991b68859c9db776a
9 N5a4f1c7da0794151a23f3541f6d65976
10 N792b4b6f27ce4421b0b7cb7738d315f1
11 Nb75fc581465c4551bb94aedb9c6cc3ad
12 Nc9a6fbc966bf44129c705bcdc35bd694
13 Ncfd17a7bdb5c4df3a8718ea5484a09f6
14 Nd254e81cd2f94af586d5372d2c5d5b78
15 Ndb426378454b47fdb9cb8e13f1f63298
16 Nee972380859a4bf9ba4af66e2ef9e2a3
17 anzsrc-for:10
18 schema:author N12fc00d878024b56b93734ad117985e1
19 schema:citation sg:pub.10.1038/336778a0
20 sg:pub.10.1186/1471-2105-11-568
21 sg:pub.10.1186/1475-2875-11-361
22 sg:pub.10.1186/1475-2875-12-136
23 schema:datePublished 2017-09-06
24 schema:datePublishedReg 2017-09-06
25 schema:description BackgroundThe parasitic disease malaria remains a major global public health concern and no truly effective vaccine exists. One approach to the development of a malaria vaccine is to target the asexual blood stage that results in clinical symptoms. Most attempts have failed. New antigens such as P27A and P27 have emerged as potential new vaccine candidates. Multiple studies have demonstrated that antigens are more immunogenic and are better correlated with protection when presented on particulate delivery systems. One such particulate delivery system is the self-assembling protein nanoparticle (SAPN) that relies on coiled-coil domains of proteins to form stable nanoparticles. In the past we have used de novo designed amino acid domains to drive the formation of the coiled-coil scaffolds which present the antigenic epitopes on the particle surface.ResultsHere we use naturally occurring domains found in the tex1 protein to form the coiled-coil scaffolding of the nanoparticle. Thus, by engineering P27A and a new extended form of the coiled-coil domain P27 onto the N and C terminus of the SAPN protein monomer we have developed a particulate delivery system that effectively displays both antigens on a single particle that uses malaria tex1 sequences to form the nanoparticle scaffold. These particles are immunogenic in a murine model and induce immune responses similar to the ones observed in seropositive individuals in malaria endemic regions.ConclusionsWe demonstrate that our P27/P27A-SAPNs induce an immune response akin to the one in seropositive individuals in Burkina Faso. Since P27 is highly conserved among different Plasmodium species, these novel SAPNs may even provide cross-protection between Plasmodium falciparum and Plasmodium vivax the two major human malaria pathogens. As the SAPNs are also easy to manufacture and store they can be delivered to the population in need without complication thus providing a low cost malaria vaccine.
26 schema:genre article
27 schema:isAccessibleForFree true
28 schema:isPartOf N3281efcd0324490fa7cb403818cc5988
29 N95c566bd907948fcb4b1f64a23b63b5d
30 sg:journal.1031280
31 schema:keywords Burkina Faso
32 C-terminus
33 ConclusionsWe
34 Faso
35 P27A
36 Plasmodium falciparum
37 Plasmodium species
38 Plasmodium vivax
39 ResultsHere
40 acid domain
41 amino acid domain
42 antigen
43 antigenic epitopes
44 approach
45 asexual blood stages
46 attempt
47 blood stages
48 candidates
49 clinical symptoms
50 coiled-coil domain
51 complications
52 concern
53 de novo
54 delivery system
55 development
56 different Plasmodium species
57 disease malaria
58 domain
59 effective vaccine exists
60 endemic regions
61 epitopes
62 exists
63 extended form
64 falciparum
65 form
66 formation
67 global public health concern
68 health concern
69 human malaria pathogen
70 immune response
71 individuals
72 major global public health concern
73 malaria
74 malaria pathogen
75 malaria vaccine
76 malaria-endemic regions
77 model
78 monomers
79 most attempts
80 multiple studies
81 murine model
82 nanoparticle scaffolds
83 nanoparticle vaccine
84 nanoparticles
85 need
86 new antigens
87 new extended form
88 new vaccine candidates
89 novo
90 one
91 p27
92 parasitic disease malaria
93 particle surface
94 particles
95 particulate delivery systems
96 past
97 pathogens
98 population
99 potential new vaccine candidates
100 protection
101 protein
102 protein monomers
103 protein nanoparticle vaccine
104 protein nanoparticles
105 public health concern
106 region
107 response
108 scaffolding
109 scaffolds
110 self-assembling protein nanoparticles
111 sequence
112 seropositive individuals
113 single particle
114 species
115 stable nanoparticles
116 stage
117 study
118 surface
119 symptoms
120 system
121 terminus
122 use
123 vaccine
124 vaccine candidates
125 vaccine exists
126 vivax
127 schema:name The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria
128 schema:pagination 62
129 schema:productId N52b573808a754177bb6d0ad53010c67e
130 N68839de2eece42868cb665b6aa9dfa4a
131 Ne7de65866a344e8992d1530f68458004
132 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091498894
133 https://doi.org/10.1186/s12951-017-0295-0
134 schema:sdDatePublished 2022-08-04T17:05
135 schema:sdLicense https://scigraph.springernature.com/explorer/license/
136 schema:sdPublisher Nc3712d77787243f5a9b9d5e907afd45b
137 schema:url https://doi.org/10.1186/s12951-017-0295-0
138 sgo:license sg:explorer/license/
139 sgo:sdDataset articles
140 rdf:type schema:ScholarlyArticle
141 N0e5162830aa24f10a3af0b4b96759042 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Malaria Vaccines
143 rdf:type schema:DefinedTerm
144 N12fc00d878024b56b93734ad117985e1 rdf:first sg:person.011611270371.37
145 rdf:rest N764de2715f8d4a74b3e65fb0bdddd432
146 N1f259d51bf8549ed8d3675e9551bd147 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Proliferating Cell Nuclear Antigen
148 rdf:type schema:DefinedTerm
149 N206e5c56b0824683836c1de6be806b7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Amino Acid Sequence
151 rdf:type schema:DefinedTerm
152 N3281efcd0324490fa7cb403818cc5988 schema:issueNumber 1
153 rdf:type schema:PublicationIssue
154 N3545a3b641d54370a7eca86820a72fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Animals
156 rdf:type schema:DefinedTerm
157 N3ad620e933264dbc9d3d0dd0667c014d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Protein Domains
159 rdf:type schema:DefinedTerm
160 N46941af2721d4e93b688a4f6a9a14854 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Antigens, Protozoan
162 rdf:type schema:DefinedTerm
163 N4770ca4cf8424f2396cb6b0c6ae6c850 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Humans
165 rdf:type schema:DefinedTerm
166 N5072683e0d0f456991b68859c9db776a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Protein Engineering
168 rdf:type schema:DefinedTerm
169 N52b573808a754177bb6d0ad53010c67e schema:name dimensions_id
170 schema:value pub.1091498894
171 rdf:type schema:PropertyValue
172 N5a4f1c7da0794151a23f3541f6d65976 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Models, Molecular
174 rdf:type schema:DefinedTerm
175 N68839de2eece42868cb665b6aa9dfa4a schema:name doi
176 schema:value 10.1186/s12951-017-0295-0
177 rdf:type schema:PropertyValue
178 N764de2715f8d4a74b3e65fb0bdddd432 rdf:first sg:person.01242722614.80
179 rdf:rest Ne91ba6161d644cce8d061d501ecdc6a4
180 N78f4d9b57a8a4df68b8a8cb3d7517f17 rdf:first sg:person.01203205441.52
181 rdf:rest rdf:nil
182 N792b4b6f27ce4421b0b7cb7738d315f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Mice
184 rdf:type schema:DefinedTerm
185 N7d28f9f114274343bb177e10c190c448 rdf:first sg:person.0727611600.80
186 rdf:rest Nc15ac71a16a54f46babe443f8eac2311
187 N95c566bd907948fcb4b1f64a23b63b5d schema:volumeNumber 15
188 rdf:type schema:PublicationVolume
189 N9a2103baa91a45168c182c903e10a515 rdf:first sg:person.0635025104.24
190 rdf:rest N7d28f9f114274343bb177e10c190c448
191 Nb75fc581465c4551bb94aedb9c6cc3ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Malaria, Falciparum
193 rdf:type schema:DefinedTerm
194 Nc15ac71a16a54f46babe443f8eac2311 rdf:first sg:person.0603746767.54
195 rdf:rest N78f4d9b57a8a4df68b8a8cb3d7517f17
196 Nc3712d77787243f5a9b9d5e907afd45b schema:name Springer Nature - SN SciGraph project
197 rdf:type schema:Organization
198 Nc9a6fbc966bf44129c705bcdc35bd694 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Immunization
200 rdf:type schema:DefinedTerm
201 Ncfd17a7bdb5c4df3a8718ea5484a09f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Nanoparticles
203 rdf:type schema:DefinedTerm
204 Nd254e81cd2f94af586d5372d2c5d5b78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Protozoan Proteins
206 rdf:type schema:DefinedTerm
207 Ndb426378454b47fdb9cb8e13f1f63298 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Mice, Inbred BALB C
209 rdf:type schema:DefinedTerm
210 Ne7de65866a344e8992d1530f68458004 schema:name pubmed_id
211 schema:value 28877692
212 rdf:type schema:PropertyValue
213 Ne91ba6161d644cce8d061d501ecdc6a4 rdf:first sg:person.01001410103.39
214 rdf:rest N9a2103baa91a45168c182c903e10a515
215 Nee972380859a4bf9ba4af66e2ef9e2a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Plasmodium falciparum
217 rdf:type schema:DefinedTerm
218 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
219 schema:name Technology
220 rdf:type schema:DefinedTerm
221 sg:grant.2457498 http://pending.schema.org/fundedItem sg:pub.10.1186/s12951-017-0295-0
222 rdf:type schema:MonetaryGrant
223 sg:journal.1031280 schema:issn 1477-3155
224 schema:name Journal of Nanobiotechnology
225 schema:publisher Springer Nature
226 rdf:type schema:Periodical
227 sg:person.01001410103.39 schema:affiliation grid-institutes:None
228 schema:familyName Paulillo
229 schema:givenName Sara M.
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001410103.39
231 rdf:type schema:Person
232 sg:person.011611270371.37 schema:affiliation grid-institutes:grid.63054.34
233 schema:familyName Karch
234 schema:givenName Christopher P.
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011611270371.37
236 rdf:type schema:Person
237 sg:person.01203205441.52 schema:affiliation grid-institutes:grid.63054.34
238 schema:familyName Burkhard
239 schema:givenName Peter
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203205441.52
241 rdf:type schema:Person
242 sg:person.01242722614.80 schema:affiliation grid-institutes:grid.63054.34
243 schema:familyName Doll
244 schema:givenName Tais A. P. F.
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242722614.80
246 rdf:type schema:Person
247 sg:person.0603746767.54 schema:affiliation grid-institutes:grid.9851.5
248 schema:familyName Corradin
249 schema:givenName Giampietro
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603746767.54
251 rdf:type schema:Person
252 sg:person.0635025104.24 schema:affiliation grid-institutes:grid.507461.1
253 schema:familyName Nebie
254 schema:givenName Issa
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0635025104.24
256 rdf:type schema:Person
257 sg:person.0727611600.80 schema:affiliation grid-institutes:grid.507680.c
258 schema:familyName Lanar
259 schema:givenName David E.
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727611600.80
261 rdf:type schema:Person
262 sg:pub.10.1038/336778a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051520883
263 https://doi.org/10.1038/336778a0
264 rdf:type schema:CreativeWork
265 sg:pub.10.1186/1471-2105-11-568 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001814252
266 https://doi.org/10.1186/1471-2105-11-568
267 rdf:type schema:CreativeWork
268 sg:pub.10.1186/1475-2875-11-361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008723107
269 https://doi.org/10.1186/1475-2875-11-361
270 rdf:type schema:CreativeWork
271 sg:pub.10.1186/1475-2875-12-136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027971905
272 https://doi.org/10.1186/1475-2875-12-136
273 rdf:type schema:CreativeWork
274 grid-institutes:None schema:alternateName Alpha-O Peptides AG, 4125, Riehen, Switzerland
275 schema:name Alpha-O Peptides AG, 4125, Riehen, Switzerland
276 rdf:type schema:Organization
277 grid-institutes:grid.507461.1 schema:alternateName Centre National de Recherche et de Formation sur le Paludisme, 01 BP 2208, Ouagadougou, West Africa, Burkina Faso
278 schema:name Centre National de Recherche et de Formation sur le Paludisme, 01 BP 2208, Ouagadougou, West Africa, Burkina Faso
279 rdf:type schema:Organization
280 grid-institutes:grid.507680.c schema:alternateName Malaria Vaccine Branch, USMMRP-WRAIR, Walter Reed Army Institute of Research, 20910, Silver Spring, MD, USA
281 schema:name Malaria Vaccine Branch, USMMRP-WRAIR, Walter Reed Army Institute of Research, 20910, Silver Spring, MD, USA
282 rdf:type schema:Organization
283 grid-institutes:grid.63054.34 schema:alternateName Department of Molecular and Cell Biology, University of Connecticut, 06269-3125, Storrs, CT, USA
284 Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA
285 schema:name Alpha-O Peptides AG, 4125, Riehen, Switzerland
286 Department of Molecular and Cell Biology, University of Connecticut, 06269-3125, Storrs, CT, USA
287 Institute of Materials Science, University of Connecticut, 06269-3136, Storrs, CT, USA
288 rdf:type schema:Organization
289 grid-institutes:grid.9851.5 schema:alternateName Biochemistry Department, University of Lausanne, 1066, Epalinges, Switzerland
290 schema:name Biochemistry Department, University of Lausanne, 1066, Epalinges, Switzerland
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...